The slight variations in extracting procedure cause many…
“The slight variations in extracting procedure cause many of the amygdalin (Vitamin B-17, Laetrile) molecules to change to a form unknown to nature(:) isomers...There are ...purveyors who label their 'iso-amygdalin' products 'amygdalin' contrary to all of the recognized specs...For commercial or political purposes, they certainly cannot justify such a fallacy...This scientific heresy and commercial fraud...(is) tremendously reducing the effectiveness of amygdalin therapy. ...To mislabel iso-amygdalin as amygdalin is scientifically, medically, and morally indefensible.”
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
Mislabeling iso‑amygdalin as amygdalin undermines scientific integrity and harms patients seeking therapy.
In simple terms: False labeling damages trust and treatment efficacy.
Key Takeaway
Demand accurate labeling and verification.
Themes
ethics
science
medicine
integrity
Mood
cautious
critical
concerned
Type
warning
informative
ethical
When to use this quote
- clinical trials
- pharmacy labeling
- patient counseling
- regulatory review
- consumer education
Key Concepts
pharmacology
regulation
misinformation
Questions to Reflect On
- How can consumers verify supplement authenticity?
- What safeguards protect patients from mislabeled products?
A Different Perspective
Scientific complexity makes verification difficult for laypeople.